Industry News

      Enterprise Therapeutics Publishes Preclinical Profile of ETD001, a Novel Inhaled ENaC Blocker

      BRIGHTON, England--(BUSINESS WIRE)--Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the...

      Foundation Medicine Announces Partnership with Repare Therapeutics to Provide Genomic Profiling Services to Support Clinical Trials and to Develop Companion Diagnostic for Lunresertib

      BOSTON--(BUSINESS WIRE)--Foundation Medicine announces a collaboration with Repare Therapeutics to provide genomic profiling for Repare’s ongoing Phase I/Ib MYTHIC study....

      bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests

      SAN ANTONIO--(BUSINESS WIRE)-- #BIAF--bioAffinity Technologies reports a 139% growth in the number of pulmonology practices and physicians ordering CyPath Lung for...

      Komodo Health Introduces the First Integrated Patient Insurance Dataset to Enhance Patient-Level Insights for Life Sciences

      SAN FRANCISCO--(BUSINESS WIRE)--Today, Komodo Health launches Komodo Patient Insurance™ (KPI), a first-of-its-kind data offering featuring in-depth insights into the insurance status...

      Worldwide Clinical Trials Ranked as Top CRO for Overall Performance In 2024 Industry Standard Research Phase II/III Benchmarking Report

      RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- #CROLeader--Worldwide Clinical Trials recognized as highest-performing Phase II/III CRO in multiple categories in the 2024 ISR...

      Sibylla Biotech and MD Anderson Announce Strategic Collaboration to Discover and Develop Small-Molecule Protein Degraders

      HOUSTON & MILAN--(BUSINESS WIRE)--Sibylla Biotech and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration agreement to...

      Recent Articles